Company overview

Get to know Exosens

Exosens is a high-tech group with over 85 years of experience in the innovation, development, manufacture and sale of high-end electro-optics technologies in the field of amplification, detection and imaging.

Exosens began its activities under the name Hyperelec as a subsidiary of Philips in 1937 at its historic site in Brive-la-Gaillarde (FR). After leaving the Philips fold in 1998, Hyperlec became Photonis by merging with Delft Electronic Products (NL) and Burle (USA). In 2021, HLD became the majority shareholder in Photonis, which changed its name to Exosens in 2023 following the acquisitions of Xenics, Proxivision, El-Mul and Telops.

Exosens offers a broad portfolio of detectors and imaging solutions such as light intensifier tubes, digital cameras with different wavelengths, ion, electron, neutron and gamma ray detectors as well as power tubes and travelling wave tubes.

Exosens sells most of its products to original equipment manufacturers (OEMs), who then integrate the products into their own systems and equipment and sell them on to their own customers, the end users facing complex issues in challenging environments in the areas of defence and surveillance, life sciences, nuclear energy and industrial control.

Exosens has established a global geographic footprint, offering its products in over 50 countries. It also has ten production and R&D located in Europe and North America. Exosens position itself as a major innovator electro-optics, with a portfolio of over 130 patents registered by the Group.

Exosens offers its products through 4 brands: Photonis, Xenics, Telops and El-Mul.

EXOSENS brands

 

Exosens is the leader in the Light Amplification market (outside the United States) and one of the leaders in the Detection and Imaging markets. The Group organises its activities around these two segments:

Exosens is the leader in the Light Amplification market (outside the United States) and one of the leaders in the Detection and Imaging markets. The Group organises its activities around these two segments:

Amplification, consisting of systems using the amplification of electrons or electromagnetic waves to produce an image or power source. The majority of amplification sales come from selling components and modules for integration into instruments and systems used by end-users in the defence sector (mainly the armed forces and internal security services).

Detection & Imaging, consisting of systems for detecting (optical or electronic) signals or generating an image from radiation in different wavelength bands of the electromagnetic spectrum. The vast majority of sales in this segment come from the sale of high value-added components and modules for integration into instruments and systems for end-users in commercial (i.e. non-defence) markets. These markets encompass sectors such as nuclear power generation, research laboratories, the oil and gas industry, the food and drink industry, life sciences, semiconductors, electronics and recycling.

More about Exosens

Exosens’ growth strategy is based on the five pillars

The Group’s ambition is to strengthen its position as a leading technology platform addressing the entire spectrum of particles and light, enabling it to pursue profitable growth by positioning itself in high- growth markets based on a need for high value-added technologies. By drawing on its strong capacity for innovation, its global commercial presence and targeted acquisitions, Exosens aims to generate a high level of profitability and cash flow. Exosens is focusing its strategy on five pillars, which benefit from significant synergies between them:

INNOVATE IN TECHNOLOGY INNOVATE IN TECHNOLOGY

Exosens intends to draw on its strong innovation capacities to develop new technologies (such as scintillators, photocathodes and artificial intelligence), improve the size, weight and energy consumption (SWAP) of its products, enhance their performance (especially sensitivity and speed), and improve product testing capacities and ergonomics. This innovation is deployed in the Group’s 4 end markets: defence, life sciences, industrial control and nuclear power.

Exosens has made a name for itself worldwide by launching a number of products featuring innovative technology, such as the 16mm image intensifier tube, which has enabled the design of night vision binoculars that are now a market benchmark, and the high-dynamic BPTOF detector for microbiology and pharmaceutical mass spectrometry.

Exosens can rely on its long-term relationships with an ecosystem of players at the cutting edge of technological innovation (university research centres, technology companies, scientific laboratories, etc.) covering all its end markets.  

FOCUS ON TARGETED NICHES FOCUS ON TARGETED NICHES

Exosens aims to be a leader in high-growth niche markets where performance standards are extremely high and critical:

  • semiconductor inspection 
  • methane detection 
  • neutron monitoring in nuclear reactors, 
  • predictive maintenance for high-voltage power lines, etc.
     

Exosens is also seeking to make its positioning difficult to replicate. To achieve this, Exosens can rely on :

  • its technological and strategic advantage, 
  • its very long-term relationships with customers and end-users, 
  • the design of products for critical applications with high standards of quality and reliability, 
  • unique industrial know-how and in-house skills,
  • operational excellence in industrial processes.

By offering products that meet the demand of high-growth niche markets, Exosens has been able to significantly increase its market share. 

GROW WITH CUSTOMERS GROW WITH CUSTOMERS

The Group intends to build on its long-term relationships with its major customers to increase and secure the repeatability of its revenue, and thus grow faster than its underlying markets.

The products sold by Exosens are generally designed in direct collaboration with the manufacturer or the end-user themselves in order to meet their specific needs throughout the life of the system, which then allows a short sales cycle once the product has been qualified by the end-user. 

CSR EMBEDDED AT CORE CSR EMBEDDED AT CORE

The Group’s strategy is geared towards pursuing business and production that contribute to the sustainable development of the economy.

Exosens products are used in a wide range of applications to help combat climate change. For example, the Group is developing products to detect methane gas in a market that is growing rapidly as a result of the development of regulations in this area. In the field of methane detection, the Group has developed hyper-spectral cameras that can identify and detect methane emissions in real time, whether by day or night, on snow or in water. 

ACCELERATE WITH SELECTIVE EXTERNAL GROWTH ACCELERATE WITH SELECTIVE EXTERNAL GROWTH

The Group’s growth strategy is based in particular on a dynamic acquisitions policy, which is intended to enable it to generate additional revenue growth through carefully targeted acquisitions of companies selected according to strict criteria and implemented in line with the characteristics of the markets in which the Group operates.

In particular, the Group targets acquisitions that can provide it with high value-added technologies and compatible with its technology platform that complement its current product portfolio, enable it to expand the addressable market and/or enable it to achieve or strengthen a leadership position, while giving the acquired targets the leverage provided by its global commercial footprint and its expertise in operational excellence, in order to accelerate the growth of the Group’s activities, improve its profitability and strengthen its cash generation.

Exosens’ external growth strategy is focused primarily on the Detection and Imaging market, with the aim of achieving a balanced split between its Amplification and Detection and Imaging activities by 2027.

Key Figures in 2023

4

Growing niche markets

130+

Patents, +15 new products a year

6%

R&D budget as a percentage of turnover

10+

R&D and production sites

1600+

Employees worldwide

300+

Customers

21+

Years commercial relationship with top 10 customers

50+

Countries, 92% overseas revenus

319M €

Pro forma 2023 sales

29%

EBITDA in 2023

70%

Cash conversion per year

7+

International acquisitions since 2022

Board of directors

Exosens - Board of directors

Jean-Hubert Vial

Chairman of the Board of Directors

Jérôme Cerisier

Jérôme Cerisier

Chief Executive Officer and director

Exosens - Board of directors

Christophe Bernardini

Director

Exosens - Board of directors

Michel Mariton

Director

Exosens - Board of directors

Wendy Kool-Foulon

Director

Exosens - Board of directors

Constance Laneque

Director

Exosens - Board of directors

HLD Europe, représentée par Salim Helou

Director

Exosens - Board of directors

François Calvarin

Censeur

Executive team

Jérôme Cerisier

Jérôme Cerisier

Chief Executive Officer

Quynh-Boi Demey

Quynh-Boi Demey

Chief Financial Officer

Claire Valentin

Claire Valentin

Chief Strategy Officer

Pascal Joseph

Pascal Joseph

Chief Operations Officer

Christel-Loic Tisse

Christel-Loic Tisse

Chief Technology Officer

Fred Lalkens

Fred Lalkens

Chief Program Officer

Frederic Guilhem

Frederic Guilhem

Chief Commercial Officer (CCO) - Night Vision

Ulrich Laupper

Ulrich Laupper

Executive General Manager - Ultimate Detection

Paul Ryckaert

Paul Ryckaert

Executive General Manager - Imaging

Larry J. Stack

Larry J. Stack

President and CEO – Photonis Defense

Jean Giroux

Jean Giroux

Executive General Manager – Instruments

POST_LK_GENERALE POST_LK_INDIVIDUALS_0 Exosens - CSR Exosens - CSR

Our CSR policy

Our Executive Committee is made up of directors in charge of Group functions and directors of key regions.

Discover